Skip to content

Ardelyx ARDX Raw materials

Raw materials at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$557M+3.5%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$658K-14.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$89K0.0%
Amgen logo
AmgenAMGN
AbbVie logo
AbbVieABBV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterials.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's raw materials?
Ardelyx (ARDX) reported raw materials of $27.94M in Q1 2026.
How has Ardelyx's raw materials changed year-over-year?
Ardelyx's raw materials decreased by 31.2% year-over-year, from $40.61M to $27.94M.
What is the long-term trend for Ardelyx's raw materials?
Over 3 years (2022 to 2025), Ardelyx's raw materials has grown at a 7.9% compound annual growth rate (CAGR), from $22.3M to $28.01M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.